Literature DB >> 31173091

Cardiovascular disease and uric acid: is the not-so-innocent bystander becoming a true culprit and does the US black box warning for febuxostat indicate that not all uric acid lowering is beneficial?

Franz H Messerli1, Michel Burnier2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31173091     DOI: 10.1093/eurheartj/ehz199

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

1.  Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Qi Chen; Zi Wang; Jingwei Zhou; Zhenjie Chen; Yan Li; Shichao Li; Hukang Zhao; Sunil V Badve; Jicheng Lv
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-14       Impact factor: 8.237

2.  Uric acid induces stress resistance and extends the life span through activating the stress response factor DAF-16/FOXO and SKN-1/NRF2.

Authors:  Qin-Li Wan; Xiaodie Fu; Wenyu Dai; Jing Yang; Zhenhuan Luo; Xiao Meng; Xiao Liu; Ruowei Zhong; Hengwen Yang; Qinghua Zhou
Journal:  Aging (Albany NY)       Date:  2020-02-12       Impact factor: 5.682

Review 3.  A lex naturalis delineates components of a human-specific, adrenal androgen-dependent, p53-mediated 'kill switch' tumor suppression mechanism.

Authors:  Jonathan Wesley Nyce
Journal:  Endocr Relat Cancer       Date:  2020-02       Impact factor: 5.678

4.  Uric acid preconditioning alleviated doxorubicin induced JNK activation and Cx43 phosphorylation associated cardiotoxicity via activation of AMPK-SHP2 signaling pathway.

Authors:  Jiawei Wang; Yixin Fan; Xiaomin Cai; Zhenzhen Gao; Zhengyi Yu; Bin Wei; Yulin Tang; Liang Hu; Wen-Tao Liu; Yanhong Gu
Journal:  Ann Transl Med       Date:  2020-12

5.  Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Authors:  Hangying Ying; Hongdi Yuan; Xiaomei Tang; Wenpu Guo; Ruhong Jiang; Chenyang Jiang
Journal:  Front Cardiovasc Med       Date:  2021-03-23

6.  Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.

Authors:  Eun Ha Kang; Eun Hye Park; Anna Shin; Jung Soo Song; Seoyoung C Kim
Journal:  Eur Heart J       Date:  2021-11-21       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.